➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Merck
Medtronic
Baxter
Express Scripts

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Miravirsen


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Miravirsen?

Miravirsen is an investigational drug.

There have been 5 clinical trials for Miravirsen. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2010.

The most common disease conditions in clinical trials are Hepatitis C, Chronic, Hepatitis C, and Hepatitis A. The leading clinical trial sponsors are Santaris Pharma A/S and [disabled in preview].

Recent Clinical Trials for Miravirsen
TitleSponsorPhase
Long-term Extension to Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis CSantaris Pharma A/SPhase 2
Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus InfectionSantaris Pharma A/SPhase 2
Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis CSantaris Pharma A/SPhase 2

See all Miravirsen clinical trials

Clinical Trial Summary for Miravirsen

Top disease conditions for Miravirsen
Top clinical trial sponsors for Miravirsen

See all Miravirsen clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Harvard Business School
McKesson
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.